AtriCure Inc (ATRC)
23.14
+0.51
(+2.25%)
USD |
NASDAQ |
May 17, 16:00
23.07
-0.07
(-0.30%)
After-Hours: 20:00
AtriCure SG&A Expense (Annual): 253.14M for Dec. 31, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 253.14M |
| December 31, 2022 | 231.27M |
| December 31, 2021 | 204.65M |
| December 31, 2020 | 150.83M |
| December 31, 2019 | 167.14M |
| December 31, 2018 | 129.52M |
| December 31, 2017 | 117.00M |
| December 31, 2016 | 106.42M |
| December 31, 2015 | 93.85M |
| December 31, 2014 | 73.51M |
| Date | Value |
|---|---|
| December 31, 2013 | 57.01M |
| December 31, 2012 | 45.06M |
| December 31, 2011 | 39.87M |
| December 31, 2010 | 37.05M |
| December 31, 2009 | 39.07M |
| December 31, 2008 | 42.42M |
| December 31, 2007 | 39.75M |
| December 31, 2006 | 33.17M |
| December 31, 2005 | 24.59M |
| December 31, 2004 | 15.17M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
150.83M
Minimum
2020
253.14M
Maximum
2023
201.41M
Average
204.65M
Median
2021
SG&A Expense (Annual) Benchmarks
| Alphatec Holdings Inc | 374.08M |
| Intuitive Surgical Inc | 1.964B |
| LeMaitre Vascular Inc | 72.89M |
| iRhythm Technologies Inc | 385.64M |
| RxSight Inc | 74.80M |